|

advertisement
|
Company Overview: |
Merck & Co., Inc is a New Jersey based pharmaceutical company giant that was founded in 1891 and engages in the discovery, development, manufacture, and marketing of various products for human and animal health. The company’s products include both therapeutic and preventive agents that are sold by prescription for the treatment and prevention of a number of human disorders as well as treatment options that address issues of animal health as well.
The company sells its products to drug wholesalers and retailers, hospitals, clinics, government agencies, and managed health care providers, such as health maintenance organizations and other institutions through its professional representatives.
|
Products and Services: |
Merck offers an expansive therapeutic drug pipeline that includes products designated as treatments for a number of targeted diseases in both humans and animals.
Zocor - is a drug for the treatment of atherosclerosis Cozaar, Hyzaar, and Vasotec - are all hypertension/heart failure treatment drug products Fosamax - is an osteoporosis drug product that is used for the treatment of osteoporosis Singulair - is a respiratory drug product and a leukotriene receptor antagonist that is used for the treatment of asthma as well as for the relief of symptoms associated with seasonal allergic rhinitis Varivax - is a live virus vaccine of chickenpox M-M-R II - is a pediatric vaccine that is used for the prevention of measles, mumps, and rubella Pneumovax - is a vaccine used to treat pneumococcal disease Recombivax HB - is a vaccine that is used for the treatment of hepatitis B Primaxin and Cancidas - are both antibacterial/antifungal therapeutic drug products Proscar - is a urology product that is used for the treatment of symptomatic benign prostate enlargement Cosopt and Trusopt - are both ophthalmological drug products Maxalt - is a drug product that is used for the treatment of acute migraine Propecia - is a drug product that is used for the treatment of male pattern hair loss
|
Key Personnel Facts: |
Richard T. Clark: Chief Executive Officer and President David W. Anstice: Executive Vice President Willie A. Deese: President, Merck Manufacturing Division Kenneth C. Frazier: Executive Vice President and General Counsel Mirian Graddick-Weir: Senior Vice President, Human Resources Peter S. Kim: President, Merck Research Laboratories Judy C. Lewent: Executive Vice President and Chief Financial Officer Peter H. Loescher: President, Global Human Health J. Chris Scalet: Senior Vice President, Global Services and CIO
Employees (2005): 61,500 1-Year Employee Growth: (2.4%)
|
Key Financial Facts: |
Fiscal Year-End: $22,011.9M 1-Year Sales Growth: (4.0%) Net Income (2005): $4,631.3M 1-Year Net Income Growth: (20.3%)
|
Back to Top
|
Jobs @ Merck
View all the jobs @ Merck
Back to Top |
Working @ Merck Have your shout about working or interveiwing at Merck
1 message posted
Message Posted:
Working @ Merck Share your experiences about working, interviewing or applying for a job at ... Author: Obi Posted: 3/8/2007 1:35:17 PM |
View or add comments about Merck
Back to Top
|
Merck in the News
- Merck: Ready for a biotech buying spree
Published: Thursday, January 26, 2006
- Merck: Ready for a biotech buying spree
Published: Thursday, January 26, 2006
- Merck's Peter S. Kim to Deliver Keynote Address at BIO CEO and Investor Conference
Published: Monday, January 23, 2006
- Clinical Data Appoints Drew Fromkin, Former Merck-Medco Executive, as Chief Marketing Officer
Published: Friday, October 21, 2005
- ParAllele BioScience and Merck Collaborate to Discover Genetic Variations in Cancer
Published: Thursday, July 07, 2005
View more news about Merck
Back To Top |
|
Merck Journal Citations
View more Merck journal citations
Back To Top |
|
|
Categories:
|
Biotechnology
|
|
Back to Top
|
|
|
|